Patents
Patents for C07K 19 - Hybrid peptides (29,428)
06/2011
06/28/2011US7968693 Nucleotide sequences coding g protein-coupled receptor for use in identifying modulators of taste transductance; artificial sweetners
06/28/2011US7968688 Antibodies that bind to the C35 polypeptide
06/28/2011US7968512 Conjugates that contain the homeodomain of antennapedia
06/28/2011US7968340 Structural protein of adeno-associated virus with modified antigenicity, its production and its use
06/28/2011CA2209300C Redirection of cellular immunity by receptor chimeras
06/23/2011WO2011074745A1 Method for producing genetically transformed rice which expresses a gene that is active in vaccination for diarrhoea by using gene recombination
06/23/2011WO2011072501A1 Fusion polypeptide against eb virus-induced tumor and colicin ia mutant
06/23/2011WO2011044698A8 Multi epitope vaccine for poultry
06/23/2011WO2011020033A3 Engineered proteins including mutant fibronectin domains
06/23/2011US20110154522 BH3 Peptides And Method Of Use Thereof
06/23/2011US20110152504 CD16A Binding Proteins and Use for the Treatment of Immune Disorders
06/23/2011US20110152173 TNF-a ANTAGONIST MULTI-TARGET BINDING PROTEINS
06/23/2011US20110151579 Secreted Epithelial Stromal-1 Molecules and Uses Thereof
06/23/2011US20110151483 Mammalian Sweet and Amino Acid Heterodimeric Taste Receptors Comprising T1R3 and T1R1
06/23/2011US20110151480 Methods of purifying zsig33
06/23/2011US20110150883 Compositions and methods for the therapy and diagnosis of breast cancer
06/23/2011US20110150874 Fusion proteins, uses thereof and processes for producing same
06/23/2011US20110150873 Anti-inflammatory compositions and combinations
06/23/2011US20110150866 Compositions and Methods for Increasing Bone Mineralization
06/23/2011US20110150768 Compositions and methods for delivering inhibitory oligonucleotides
06/23/2011CA2784784A1 Fusion polypeptide against eb virus-induced tumor and colicin ia mutant
06/23/2011CA2784093A1 Wise binding agents and epitopes
06/22/2011EP2336322A1 Inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
06/22/2011EP2336308A2 Enzymes for starch processing
06/22/2011EP2336169A1 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same
06/22/2011EP2335728A1 Specific binding proteins and uses thereof
06/22/2011EP2335726A1 Fusion molecules and methods for treatment of immune diseases
06/22/2011EP2335718A1 Non-cytotoxic protein conjugates
06/22/2011EP2335716A2 Pancreatic polypeptide family motifs and polypeptides comprising the same
06/22/2011EP2335715A2 Pancreatic polypeptide family motifs and polypeptides comprising the same
06/22/2011EP1324771B1 Therapeutic and tolerance inducing antibodies
06/22/2011DE102009055015A1 Hefe-Sekretionssystem auf Basis einer Signalsequenz aus der Hydrophobin 1-Gensequenz von Trichoderma reesei Yeast secretion system on the basis of a signal sequence of the hydrophobin 1 gene sequence of Trichoderma reesei
06/22/2011CN102101889A Prokaryotic expression protein of VP73 gene from African swine fever virus and preparation method thereof
06/22/2011CN102101888A Novel polypeptide for resisting tumors caused by EB (Epstein-Barr) viruses, and application and preparation method thereof
06/22/2011CN101284876B Fusion protein Penharpin, preparation method and use
06/22/2011CN101173008B Double-function amalgamation protein, preparation method and application thereof
06/21/2011US7964713 Nucleotide sequences which code polypeptide for use in human therapeutics ad diagnostics
06/21/2011US7964712 Chimeric nucleic acids encoding polypeptides comprising TNF alpha, CD70 and FAS ligand domains
06/21/2011US7964711 Compositions comprising polynucleotides encoding TACI-immunoglobulin fusion proteins and methods for producing the same
06/21/2011US7964703 DNAX Cytokine Receptor Subunits (DCRS) 5 cytokine receptors modulators; multiple sclerosis, rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, diabetes, psoriasis, sepsis or in allogeneic transplant; chronic Th1 mediated disease
06/21/2011US7964376 Chimeric proteins and their use in methods to screen for sweet taste modulators
06/21/2011CA2386471C Purification of recombinant proteins fused to multiple epitopes
06/21/2011CA2198966C Method for cleaving chimeric protein using processing enzyme
06/16/2011WO2011071783A1 Human antigen binding proteins that bind beta-klotho, fgf receptors and complexes thereof
06/16/2011WO2011071280A2 Intracelluar targeting bipodal peptide binder
06/16/2011WO2011071279A2 Bpb-based cargo delivery system
06/16/2011WO2011028344A3 Interleukin-1 receptor antagonist compositions and methods of making and using same
06/16/2011WO2011002977A3 Genetically encoded photomanipulation of protein and peptide activity
06/16/2011US20110143994 Compositions and methods for treatment of autoimmune and allergic diseases
06/16/2011US20110143991 Peptides for Activation and Inhibition of Delta-PKC
06/16/2011US20110143963 Molecular affinity clamp technology and uses thereof
06/16/2011US20110143417 Stably Tethered Structures of Defined Compositions with Multiple Functions or Binding Specificities
06/16/2011US20110142872 Compounds and methods for treatment and diagnosis of chlamydial infection
06/16/2011US20110142869 Membrane proximal region of hiv gp41 anchored to the lipid layer of a virus-like particle vaccine
06/16/2011US20110142792 Compositions for Increasing Polypeptide Stability and Activity, and Related Methods
06/16/2011US20110142791 Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors
06/16/2011US20110142763 Megalin-Based Delivery of Therapeutic Compounds to the Brain and Other Tissues
06/16/2011CA2783876A1 New conjugates and compositions for immunotherapy and antitumoral treatment
06/16/2011CA2782420A1 Human antigen binding proteins that bind .beta.-klotho, fgf receptors and complexes thereof
06/15/2011EP2333069A2 Therapeutic uses of IL-17 homologous polypeptides
06/15/2011EP2333065A1 Novel MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1
06/15/2011EP2333064A1 Nucleotide and protein sequences of Nogo genes and methods based thereon
06/15/2011EP2332978A1 Novel polypeptides involved in immune response
06/15/2011EP2332976A1 Novel polypeptides involved in immune response
06/15/2011EP2332974A2 Osteoprotegerin
06/15/2011EP2332970A2 Mutated pseudomonas exotoxins with reduced antigenicity
06/15/2011EP2331693A2 An expression vector and a method thereof
06/15/2011EP2331580A1 Multifunctional linker protein containing an antibody against hemagglutinin, a conserved influenza antigen and an immunostimulating carrier binding domain
06/15/2011EP1597585B1 Method for selecting a candidate drug compound
06/15/2011CN1452636B Human monoclonal antibodies to dendritis cells
06/15/2011CN102094034A Process for purifying recombinant human Fc fusion pegylated interferon
06/15/2011CN102093480A Recombinant human serum albumin-interferon alpha 1b fusion protein and preparation method thereof
06/15/2011CN101434964B Cholera toxin B subunit and lumbrokinase fusion gene, as well as recombinant vector and host cell including the same
06/15/2011CN101397562B Construction method for major histocompatibility complex/peptide tetramer for chicken and products thereof
06/15/2011CN101144093B Recombination expression carrier and method for soluble expressing human I-type metallothionin
06/15/2011CN101063123B Preparation method for fused protein of human C-type diuresis promotion sodium peptide and human serum albumins and its product
06/15/2011CN101012282B Manual transcription factor and highly effective expression method in CHO cell of promotion exogenesis gene thereof
06/14/2011US7960514 IL-7 fusion proteins
06/14/2011US7960128 TRP8, a transient receptor potential channel expressed in taste receptor cells
06/14/2011US7960127 Using channel protein to identify inhibitors of bitter and/or sweet taste preception
06/14/2011US7959933 Activatable recombinant neurotoxins
06/14/2011CA2413546C Modification of hepatitis b core antigen
06/09/2011WO2011068993A1 Compositions and methods for increasing serum half-life of fc fusion proteins.
06/09/2011WO2011068853A2 TREATMENT OF IgE-MEDIATED DISEASE
06/09/2011WO2011068538A2 General method for generating ultra-high affinity binding proteins
06/09/2011US20110136155 Peptides and methods for the detection of lyme disease antibodies
06/09/2011US20110135680 Deletion mutants of flagellin and methods of use
06/09/2011US20110135644 Methods and compositions for enhanced delivery of macromolecules
06/09/2011CA2782320A1 Compositions and methods for increasing serum half-life of fc fusion proteins
06/08/2011EP2330198A1 IL-1 related polypeptides
06/08/2011EP1919513B1 Targeted vector comprising a cyclodecapeptide RAFT and an activable imaging function
06/08/2011EP1791961B1 Protein production method utilizing yebf
06/08/2011CN102089432A Soluble recombinant influenza antigens
06/08/2011CN102089328A Mutants of streptokinase and their covalently modified forms
06/08/2011CN102089323A Modulators of MYC, methods of using the same, and methods of identifying agents that modulate MYC
06/08/2011CN102086459A Fusion protein immunosuppressive agent and preparation method and application thereof
06/08/2011CN102086231A Fusion protein comprising ubiquitin or ubiquitin-like protein, membrane translocation sequence and biologically active molecule and use thereof
06/08/2011CN101456913B Anti-tumor fusion protein and use thereof
06/08/2011CN101139613B Antineoplastic dibasic polypeptide and application and preparation method thereof
06/07/2011US7956160 Freeze dried protein composition comprising manitol polymorphs which reconstitute quickly upon addition of diluent and provide solutions of high protein concentrations, with reduced formation of foam, effervescence, bubbles, aggregates and particulates
1 ... 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 ... 295